Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies

PURPOSE: Chemotherapy-induced neutropenia (CIN) increases the risk of infections and mortality in cancer patients. G-CSF therapies are approved for the treatment of CIN, but non-G-CSF therapies are needed to increase efficacy and minimize side effects. Plinabulin is an inhibitor of tubulin polymeriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonra, James R., Lloyd, G. Kenneth, Mohanlal, Ramon, Huang, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015961/
https://www.ncbi.nlm.nih.gov/pubmed/31811421
http://dx.doi.org/10.1007/s00280-019-03998-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015961/
https://www.ncbi.nlm.nih.gov/pubmed/31811421
http://dx.doi.org/10.1007/s00280-019-03998-w

Ejemplares similares